DrugsControl Media Services
DrugsControl.org

News Detail

Lupin Acquires Brands Ondero® and Ondero Met® from Boehringer Ingelheim (19-08-2023)

Mumbai, 18 Aug 2023: Global pharma major Lupin Limited (Lupin) announced today the acquisition of diabetes brands ONDERO® and ONDERO MET®, from Boehringer Ingelheim International GmbH (Boehringer Ingelheim), including the trademark rights associ......
View Details

Source : DrugsControl Media Services
lupin diabetes brands Boehringer Ingelheim acquisition Ondero® Ondero Met®

Related News